undefined
EUTM file information

018274501

ISTRELZO


July 19, 2020

Trademark Summary

The trademark ISTRELZO was filed by Johnson & Johnson, a U.S. corporation (the "Applicant"). The application was published for oppositions on September 30, 2020, and received one opposition filed on January 3, 2021 by Istesso Limited on Likelihood of confusion. the opponent was represented by Marks & Clerk LLP and proceedings were handled in English, and the oppositon was dismissed by the Euorpean Union Intellectual Property Office with decision issued January 3, 2021

The application was filed in Dutch, and Dutch was also language of all opposition proceedings (English was selected as the second language).

Appointment and Replacement of representative of the trademark registration was recorded on December 19, 2022.


Goods And Services

  • The mark was filed in class 5 with Human pharmaceuticals for the treatment of cancer, excluding human pharmaceuticals for the treatment of autoimmune conditions,rheumatoid arthritis, and multiple sclerosis.